HIF3A
Hypoxia-inducible factor 3 alpha (HIF3A) is a protein that in humans is encoded by the HIF3A gene. It is a member of the hypoxia-inducible factors (HIFs) family, which play a crucial role in the body's response to oxygen levels. HIF3A, like other HIFs, is involved in the cellular response to hypoxia, a condition where there is a lack of oxygen in the tissues.
Function[edit | edit source]
HIF3A is involved in the complex regulatory pathways that allow cells to adapt to and survive under low oxygen conditions. It does so by activating the transcription of various genes that facilitate adaptive responses, such as increasing angiogenesis (the formation of new blood vessels), altering metabolism to less oxygen-dependent forms, and promoting cell survival mechanisms. Unlike its more studied counterparts, HIF1A and HIF2A, the specific roles and mechanisms of HIF3A are less understood. However, it is believed to act as a regulator of the other HIFs, potentially by limiting their activity in certain contexts to fine-tune the hypoxic response.
Structure[edit | edit source]
The HIF3A protein is structured similarly to other members of the HIF family, containing a basic helix-loop-helix (bHLH) domain for DNA binding, a Per-ARNT-Sim (PAS) domain for dimerization, and an oxygen-dependent degradation domain (ODD) that regulates its stability in an oxygen-dependent manner. Under normal oxygen conditions, HIF3A is rapidly degraded, but under hypoxic conditions, it stabilizes and translocates to the nucleus to exert its functions.
Clinical Significance[edit | edit source]
Research has suggested that HIF3A may play roles in various diseases, particularly those where hypoxia is a key component, such as certain types of cancer, cardiovascular diseases, and chronic kidney disease. Its involvement in these conditions is thought to be through its effects on angiogenesis, metabolism, and cell survival pathways. Additionally, variations in the HIF3A gene have been associated with susceptibility to obesity and type 2 diabetes, indicating its potential role in metabolic regulation.
Genetics[edit | edit source]
The HIF3A gene is located on chromosome 19 in humans. Variants within this gene have been studied for their association with diseases and traits, such as body mass index (BMI) and fat distribution, suggesting that HIF3A could influence metabolic processes beyond its role in hypoxia response.
Research Directions[edit | edit source]
Ongoing research aims to further elucidate the specific functions and mechanisms of HIF3A in hypoxia and its potential as a therapeutic target. Understanding how HIF3A interacts with other HIFs and cellular pathways could lead to new approaches in treating diseases where hypoxia is a factor.
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD